BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries

  September 4, 2024

   · 

  11 min read
• Press Releases

  Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c) - September 3, 2024

  September 4, 2024

   · 

  6 min read
• Press Releases

  EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody

  September 4, 2024

   · 

  3 min read
• Press Releases

  Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression for up to 48 weeks in patients with relapsing multiple sclerosis

  September 4, 2024

   · 

  9 min read
• Press Releases

  Caris Life Sciences to Showcase Research Highlighting the Clinical Value of Comprehensive Molecular Profiling at ESMO 2024

  September 4, 2024

   · 

  4 min read
• Press Releases

  Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - September 3, 2024

  September 4, 2024

   · 

  2 min read
• Press Releases

  Pharming Group to participate in September 2024 investor conferences

  September 4, 2024

   · 

  1 min read
• Press Releases

  Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

  September 4, 2024

   · 

  3 min read